Economic Times |
India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden
Reuters MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will … Cipla targets US with asthma, HIV drugs |
View full post on asthma – Google News